Navigation Links
Pharmasset to Present at the Lazard Capital Markets Healthcare Conference
Date:11/13/2011

rimidine, PSI-7977, an unpartnered uracil nucleotide analog, is currently being studied in an interferon-free, Phase 3 program (FISSION and POSITRON) and in five Phase 2b trials in subjects with all HCV genotypes. Our purine, PSI-938, an unpartnered guanosine nucleotide analog, is in QUANTUM, a Phase 2b interferon-free trial of PSI-7977 and PSI-938 in subjects with all HCV genotypes. Mericitabine (RG7128) continues in three Phase 2b trials and one interferon-free trial being conducted through a strategic collaboration with Roche.ContactRichard E. T. Smith, Ph.D.VP, Investor Relations and Corporate CommunicationsOffice +1 (609) 865-0693 Forward-Looking StatementsPharmasset "Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Statements in this press release that are not historical facts are "forward-looking statements," that involve risks, uncertainties, and other important factors, including, without limitation, the risk of cessation or delay of any of the ongoing or planned clinical trials and/or our development of our product candidates, the risk that the results of previously conducted studies involving our product candidates will not be repeated or observed in ongoing or future studies involving our product candidates, the risk that our collaboration with Roche will not continue or will not be successful, and the risk that any one or more of our product candidates will not be successfully developed and commercialized. For a discussion of risks, uncertainties, and other important factors, any of which could cause our actual results to differ from those contained in the forward-looking statements, see the section entitled "Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended September 30, 2010 and our Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission and discussions of potential risks, uncertainties, and other important factors in our subsequent filings with the Securities
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Pharmasset to Webcast an Investor Event from the AASLD Meeting
2. Pharmasset to Present at Four Upcoming Investor Conferences
3. Pharmasset to Present at Canaccord Adams Conference
4. Pharmasset Reports Fiscal Second Quarter 2009 Financial Results
5. InterMune and Pharmasset to Discuss INFORM-1 Results From EASL Conference, April 25
6. Pharmasset Reports Fiscal First Quarter 2009 Financial Results
7. Pharmasset Announces $45.5 Million Registered Direct Offering of Common Stock
8. Pharmasset and Roche Obtain FDA Consent to Start a Phase 2b Study With R7128 in Treatment Naive HCV Patients
9. Pharmasset to Present at Two Upcoming Investor Conferences
10. Pharmasset to Present at the Natixis Bleichroeder Hidden Gems Conference on Monday, October 13th
11. Pharmasset to Present at the JMP Securities Healthcare Focus Conference on Monday, October 6th
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... Jose, California (PRWEB) September 22, 2014 ... The primal desire to stay young has groomed ... multi-billion dollar industry worldwide. Growing emphasis on appearance ... Botulinum Toxin is a neurotoxic protein obtained from ... of acetylcholine, resulting in muscle relaxation. With cosmetic ...
(Date:9/22/2014)... (Nasdaq: NEOG ) announced today that net ... year, which ended Aug. 31, was $8,883,000 — a ... the first quarter of last year. Adjusted for a ... share in the current quarter were $0.24, compared to ... increased 15% to $67,599,000, from the previous year,s first ...
(Date:9/22/2014)... METTLER TOLEDO is pleased to launch ... CNS110 ScanTape™ . Replacing a traditional tape ... ease and accuracy for transport and logistics personnel. ... productivity—an important benefit for load planning and revenue ... , Usable at any point in goods-transfer ...
(Date:9/21/2014)... time, scientists have discovered how to produce ultra-thin "diamond ... greater than that of today,s strongest nanotubes and polymers. ... led by John V. Badding, a professor of chemistry ... 21 September 2014 issue of the journal Nature ... our discovery is intriguing because the threads we formed ...
Breaking Biology Technology:Strong Demand for Non-Invasive Cosmetic Procedures Drives the Global Botulinum Toxin Market, According to New Report by Global Industry Analysts, Inc. 2Strong Demand for Non-Invasive Cosmetic Procedures Drives the Global Botulinum Toxin Market, According to New Report by Global Industry Analysts, Inc. 3Neogen reports 13% net income increase 2Neogen reports 13% net income increase 3Neogen reports 13% net income increase 4Neogen reports 13% net income increase 5Neogen reports 13% net income increase 6Neogen reports 13% net income increase 7ScanTape™ Handheld Dimensioner Increases Processing Volume 2Smallest possible diamonds form ultra-thin nanothreads 2Smallest possible diamonds form ultra-thin nanothreads 3Smallest possible diamonds form ultra-thin nanothreads 4
... Amarin Corporation plc,(NASDAQ: AMRN ) today announced ... to commence a Phase IIa trial in Age,Associated Memory ... IIa trial will be a randomized, double-blind,placebo-controlled study. The ... randomized to receive 1, 2 or 4 grams of ...
... Caliper Life,Sciences, Inc. (Nasdaq: CALP ) President ... 26th Annual Healthcare Conference in San Francisco,California, today, ... Mr.,Hrusovsky will discuss Caliper,s outlook for 2008, and ... 2007., Based on preliminary, unaudited financial data ...
... Hagens Berman Sobol Shapiro LLP,( http://www.hbsslaw.com/cellcyte.htm ) ... of CellCyte (OTC Bulletin Board: CCYG) for ... comes after CellCyte,s shares plunged 55 percent,after ... CEO Gary,Reys, educational and professional credentials., ...
Cached Biology Technology:Amarin to Commence Phase II Trial With AMR101 in Age Associated Memory Impairment 2Amarin to Commence Phase II Trial With AMR101 in Age Associated Memory Impairment 3Amarin to Commence Phase II Trial With AMR101 in Age Associated Memory Impairment 4Caliper Life Sciences to Present at JPMorgan 26th Annual Healthcare Conference Today 2Hagens Berman Sobol Shapiro Investigating CellCyte 2
(Date:9/22/2014)... GAINESVILLE, Fla. --- Many native species have vanished ... University of Florida scientists have discovered how fossils ... , The key lies in organic materials found ... ancient ecosystems functioned, according to a new study ... the Journal of Herpetology . Pre-human island ...
(Date:9/22/2014)... September 22, 2014Cassava, also known as tapioca, has large ... areas of Africa, Asia, and Latin America where corn ... of novel enzymes and processes designed to break down ... to produce sweeteners such as glucose, fructose, or maltose ... as described in a Review article in Industrial ...
(Date:9/22/2014)... In 2011 the Society of Environmental Toxicology and Chemistry ... identify and prioritize the scientific research needed to understand ... in the environment. The effort was extended, and ... the Society,s international journal, Integrated Environmental Assessment and ... by a podcast interviewing the lead author of the ...
Breaking Biology News(10 mins):Answer to restoring lost island biodiversity found in fossils 2Priorities for research on pharmaceutical and personal care products in the environment 2
... October 1, 2008 - As a nutrient, sulfur is ... but a new book explains its crucial role in ... understanding how plants use sulfur is essential for optimizing ... Link Between Soils, Crops and Nutrition , a new ...
... What: To stop cancer before it has a ... turning their attention to new discoveries in cancer prevention. ... share the latest research in this expanding and promising ... reduce cancer incidence and mortality. To help you ...
... tiny and often unappreciated rodents, mammals on Earth are in ... Earth is being pushed to extinction, according to the Global ... Writing in the October 10 issue of ... Mammals: Diversity, Threat, and Knowledge") and unveiling a "Red List" ...
Cached Biology News:Researchers document world's mammals in crisis 2Researchers document world's mammals in crisis 3Researchers document world's mammals in crisis 4
PC based system for advanced chemifluorescent, chemiluminescent, fluorescent and colorimetric, microarray and microscope imaging and analysis....
PC based system for superior chemifluorescent, chemiluminescent, fluorescent and colorimetric, microarray and microscope imaging and analysis....
Rabbit Polyclonal antibody to Perilipin Applications: This antibody is useful for Western blot anlaysis where a band at ~60 kDa is seen....
Conveniently document gels, films and membranes with a high quality thermal printer. , Compact, footprint printer , Supplies 256 gray scale for high resolution, archive-quality thermal film prints...
Biology Products: